Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

Clinical trial NCT00405392 · COMPLETED

Trial details

NCT number: NCT00405392
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Osteoporosis, Postmenopausal

Start date: 2007-03-22
Primary completion: 2008-05-27
Enrollment: 365

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.